澳洋健康
(002172)
| 流通市值：28.32亿 | | | 总市值：28.33亿 |
| 流通股本：7.65亿 | | | 总股本：7.66亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 452,119,969.79 | 2,009,775,237.99 | 1,501,392,158.94 | 1,031,673,386.92 |
| 营业收入 | 452,119,969.79 | 2,009,775,237.99 | 1,501,392,158.94 | 1,031,673,386.92 |
| 二、营业总成本 | 428,104,319.98 | 1,950,426,263.79 | 1,443,960,814.85 | 985,610,124.05 |
| 营业成本 | 383,913,440.39 | 1,740,737,383.15 | 1,295,449,367.85 | 892,554,002.46 |
| 税金及附加 | 2,494,922.69 | 11,087,149.35 | 8,073,208.03 | 5,173,051.25 |
| 销售费用 | 8,585,056.64 | 42,609,496.87 | 32,167,433.29 | 21,540,246.14 |
| 管理费用 | 25,548,561.28 | 124,354,499.52 | 92,868,985.94 | 60,413,296.48 |
| 研发费用 | - | - | 0 | 0 |
| 财务费用 | 7,562,338.98 | 31,637,734.9 | 15,401,819.74 | 5,929,527.72 |
| 其中:利息费用 | 6,168,699.53 | 39,380,870.42 | 32,794,633.63 | 20,903,912.87 |
| 其中:利息收入 | 1,319,959.91 | 22,504,211.87 | 22,325,884.44 | 19,767,766.31 |
| 加:投资收益 | -270,329.68 | -1,312,375.05 | -460,456.68 | -386,950.6 |
| 资产处置收益 | 0 | -59,174.03 | -5,898.86 | -6,595.6 |
| 信用减值损失(新) | -577,670.25 | -2,661,266.95 | 4,848,236.73 | 5,470,251.98 |
| 其他收益 | 394,156.99 | 12,292,417.79 | 1,478,419.13 | 767,329.1 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 23,561,806.87 | 67,608,575.96 | 63,291,644.41 | 51,907,297.75 |
| 加:营业外收入 | 690,333.2 | 866,376.17 | 4,700,827.78 | 4,314,318.74 |
| 减:营业外支出 | 55,419.56 | 3,298,896.95 | 3,161,868.6 | 1,787,841.14 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 24,196,720.51 | 65,176,055.18 | 64,830,603.59 | 54,433,775.35 |
| 减:所得税费用 | 5,341,713.4 | 23,935,072.55 | 25,207,774.87 | 16,381,096.02 |
| 六、净利润 | 18,855,007.11 | 41,240,982.63 | 39,622,828.72 | 38,052,679.33 |
| 持续经营净利润 | 18,855,007.11 | 41,240,982.63 | 39,622,828.72 | 38,052,679.33 |
| 归属于母公司股东的净利润 | 18,499,176.25 | 40,561,915.31 | 38,678,072.35 | 37,327,960.74 |
| 少数股东损益 | 355,830.86 | 679,067.32 | 944,756.37 | 724,718.59 |
| (一)基本每股收益 | 0.02 | 0.05 | 0.05 | 0.05 |
| (二)稀释每股收益 | 0.02 | 0.05 | 0.05 | 0.05 |
| 八、其他综合收益 | - | 83,294.05 | - | - |
| 归属于母公司股东的其他综合收益 | - | 83,294.05 | - | - |
| 九、综合收益总额 | 18,855,007.11 | 41,324,276.68 | 39,622,828.72 | 38,052,679.33 |
| 归属于母公司股东的综合收益总额 | 18,499,176.25 | 40,645,209.36 | 38,678,072.35 | 37,327,960.74 |
| 归属于少数股东的综合收益总额 | 355,830.86 | 679,067.32 | 944,756.37 | 724,718.59 |
| 公告日期 | 2025-04-30 | 2025-04-15 | 2024-10-31 | 2024-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |